Cisplatin/Durvalumab/Pemetrexed Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cisplatin, durvalumab, and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Cisplatin-Durvalumab-Pemetrexed - Cisplatin/Durvalumab/Pemetrexed - Cisplatin/Imfinzi/Alimta - Cisplatin/Pemetrexed Plus Durvalumab - Cisplatin/Pemetrexed/Durvalumab - Durvalumab Plus Cisplatin/Pemetrexed - Pemetrexed/Cisplatin Plus Durvalumab